Abstract:Carpal tunnel syndrome (CTS) is a compression neuropathy of the median nerve at the wrist. Surgery is considered when symptoms persist despite the use of non‐surgical treatments. It is unclear whether surgery produces a better outcome than non‐surgical therapy. This is an update of a Cochrane review published in 2008. To assess the evidence regarding the benefits and harms of carpal tunnel release compared with non‐surgical treatment in the short ( 3 months) term. In this update, we included studies from the previous version of this review and searched the Cochrane Neuromuscular Specialised Register, CENTRAL, Embase, MEDLINE, ClinicalTrials.gov and WHO ICTRP until 18 November 2022. We also checked the reference lists of included studies and relevant systematic reviews for studies. We included randomised controlled trials comparing any surgical technique with any non‐surgical therapies for CTS. We used the standard methodological procedures expected by Cochrane. The 14 included studies randomised 1231 participants (1293 wrists). Eighty‐four per cent of participants were women. The mean age ranged from 32 to 53 years, and the mean duration of symptoms from 31 weeks to 3.5 years. Trial sizes varied from 22 to 176 participants. The studies compared surgery with: splinting, corticosteroid injection, splinting and corticosteroid injection, platelet‐rich plasma injection, manual therapy, multimodal non‐operative treatment, unspecified medical treatment and hand support, and surgery and corticosteroid injection with corticosteroid injection alone. Since surgery is generally used for its long‐term effects, this abstract presents only long‐term results for surgery versus splinting and surgery versus corticosteroid injection. 1) Surgery compared to splinting in the long term (> 3 months) Surgery probably results in a higher rate of clinical improvement (risk ratio (RR) 2.10, 95% confidence interval (CI) 1.04 to 4.24; 3 studies, 210 participants; moderate‐certainty evidence). Surgery probably does not provide clinically important benefit in symptoms or hand function compared with splinting (moderate‐certainty evidence). The mean Boston Carpal Tunnel Questionnaire (BCTQ) Symptom Severity Scale (scale 1 to 5; higher is worse; minimal clinically important difference (MCID) = 1) was 1.54 with splint and 0.26 points better with surgery (95% CI 0.52 better to 0.01 worse; 2 studies, 195 participants). The mean BCTQ Functional Status Scale (scale 1 to 5; higher is worse; MCID 0.7) was 1.75 with splint and 0.36 points better with surgery (95% CI 0.62 better to 0.09 better; 2 studies, 195 participants). None of the studies reported pain. Surgery may not provide better health‐related quality of life compared with splinting (low‐certainty evidence). The mean EQ‐5D index (scale 0 to 1; higher is better; MCID 0.074) was 0.81 with splinting and 0.04 points better with surgery (95% CI 0.0 to 0.08 better; 1 study, 167 participants). We are uncertain about the risk of adverse effects (very low‐certainty evidence). Adverse effects were reported amongst 60 of 98 participants (61%) in the surgery group and 46 of 112 participants (41%) in the splinting group (RR 2.11, 95% CI 0.37 to 12.12; 2 studies, 210 participants). Surgery probably reduces the risk of further surgery; 41 of 93 participants (44%) were referred to surgery in the splinting group and 0 of 83 participants (0%) repeated surgery in the surgery group (RR 0.03, 95% CI 0.00 to 0.21; 2 studies, 176 participants). This corresponds to a number needed to treat for an additional beneficial outcome (NNTB) of 2 (95% CI 1 to 9). 2) Surgery compared to corticosteroid injection in the long term (> 3 months ) We are uncertain if clinical improvement or symptom relief differs between surgery and corticosteroid injection (very low‐certainty evidence). The RR for clinical improvement was 1.23 (95% CI 0.73 to 2.06; 3 studies, 187 participants). For symptoms, the standardised mean difference (SMD) was ‐0.60 (95% CI ‐1.88 to 0.69; 2 studies, 118 participants). This translates to 0.4 points better (95% CI from 1.3 better to 0.5 worse) on the BCTQ Symptom Severity Scale. Hand function or pain probably do not differ between surgery and corticosteroid injection (moderate‐certainty evidence). For function, the SMD was ‐0.12 (95% CI ‐0.80 to 0.56; 2 studies, 191 participants) translating to 0.10 points better (95% CI 0.66 better to 0.46 worse) on the BCTQ Functional Status Scale with surgery. Pain (0 to 100 scale) was 8 points with corticosteroid injection and 6 points better (95% CI 10.45 better to 1.55 better; 1 study, 123 participants) with surgery. We found no data to estimate the difference in health‐related quality of life (very low‐certainty evidence). We are uncertain about the risk of adverse effects and further surgery (very low‐certainty evidence). Adverse effects were reported amon -Abstract Truncated-

Wrist Immobilization after Surgical Decompression of the Median Nerve in Carpal Tunnel Syndrome: A Systematic Review

Research progress on the diagnoses and rehabilitation for cubital tunnel syndrome: A narrative review

Surgical Interventions for the Management of Carpal Tunnel Syndrome: A Narrative Review

The significance of wrist immobilization for endoscopic carpal tunnel release

Research advances and trends in the surgical treatment of carpal tunnel syndrome from 2003 to 2022: A CiteSpace-based bibliometric analysis

Carpal Tunnel Syndrome: A Review of Literature

Comparison of the Short-Term and Long-Term Effects of Surgery and Nonsurgical Intervention in Treating Carpal Tunnel Syndrome: A Systematic Review and Meta-Analysis

Carpal Tunnel Syndrome: Rapid Evidence Review

Causes of Iatrogenic Median Nerve Injury after Endoscopic Carpal Tunnel Release

Manual Therapy vs. Surgery: Which Is Best for Carpal Tunnel Syndrome Relief?

Surgical versus non-surgical treatment for carpal tunnel syndrome

Treatment options for digital nerve injury: a systematic review and meta-analysis

State of the art review. Complications after carpal tunnel release

Are there any benefits for post-operative splinting after carpal tunnel release? A systematic review and meta-analysis

Effect of Wrist Dorsiflexion/Palmar Flexion on Median Nerve Deviation and Cross-Sectional Area in Patients with Carpal Tunnel Syndrome

Effectiveness of Platelet-Rich Plasma for Patients With Carpal Tunnel Syndrome: A Systematic Review and meta-Analysis of Current Evidence in Randomized Controlled Trials

Normal Palmar Anatomy and Variations That Impact Median Nerve Decompression

The Value of Ultrasonography in Patients with Carpal Tunnel Syndrome Who Received Surgical Intervention

The effectiveness of passive physical modalities for the management of soft tissue injuries and neuropathies of the wrist and hand: a systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) collaboration

State of the art review. Upper extremity revision nerve compression surgery

Altered brain function and structure in carpal tunnel syndrome: a systematic review and meta-analysis of structural and functional brain imaging